Home › COVID-19 and Coronavirus Infections › North Carolina › Durham
COVID-19 and Coronavirus Infections clinical trials in Durham, NC
5 studies for COVID-19 and Coronavirus Infections are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingPhase 3
- Research Site, Durham
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- Duke Vaccine and Trials Unit, Durham
- Duke Vaccine and Trials Unit, Durham
- Duke University - Main Hospital and Clinics, Durham
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
RecruitingObservational studyHealthy volunteers welcome
- Duke University Health System, Durham
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
RecruitingPhase 4Healthy volunteers welcome
- Duke Vaccine and Trials Unit, Durham
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
RecruitingPhase 3
- Duke University, Durham
COVID-19 and Coronavirus Infections trials in other cities
- Washington, DC7 studies
- Houston, TX5 studies
- Dallas, TX5 studies
- Boston, MA5 studies
- Atlanta, GA5 studies
- Los Angeles, CA4 studies
- New York City, NY4 studies
- Hialeah, FL4 studies
- San Francisco, CA3 studies
- Cincinnati, OH3 studies
- Pittsburgh, PA3 studies
- Chicago, IL3 studies
Other studies in Durham
- Breast Cancer64 studies
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Acute Myeloid Leukemia33 studies
- Metastatic Cancer33 studies
- Prostate Cancer32 studies
- Lung Cancer32 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Chronic Lymphocytic Leukemia27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.